Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Alzheimer's Disease Neuroimaging Initiative"'
Autor:
Amir Ashraf-Ganjouei, Kamyar Moradi, Shahriar Faghani, AmirHussein Abdolalizadeh, Mohammadreza Khomeijani-Farahani, Farzad Fatehi, null Alzheimer's Disease Neuroimaging Initiative
Publikováno v:
Current Alzheimer research. 18(9)
Background: Mild cognitive impairment (MCI) is a state between normal cognition and dementia. However, MCI diagnosis does not necessarily guarantee the progression to dementia. Since no previous study investigated brain positron emission tomography (
Autor:
Alzheimer’s Disease Neuroimaging Initiative, Gorana Capkun, Angelika Caputo, Luyuan Qi, V Risson, H Karcher, Noemi Hummel, Marina Savelieva
Publikováno v:
Current Alzheimer research. 17(7)
Objective: : The study aimed to evaluate and quantify the temporal link between cognitive and functional decline, and assess the impact of the apolipoprotein E4 (APOE-e4) genotype on Alzheimer’s disease (AD) progression. Methods: A nonlinear mixed-
Autor:
Zhongke Gao, Yanhua Feng, Chao Ma, Kai Ma, Qing Cai, null and for the Alzheimer’s Disease Neuroimaging Initiative
Publikováno v:
Current Alzheimer research. 17(1)
Background: Alzheimer's Disease (AD) is a progressive neurodegenerative disease with insidious onset, which is difficult to be reversed and cured. Therefore, discovering more precise biological information from neuroimaging biomarkers is crucial for
Autor:
Alzheimer’s Disease Neuroimaging Initiative, Peter Bartenstein, Andreas Delker, Stefan Förster, Sonja Därr, Eva Kalinowski, Matthias Brendel, Oliver Pogarell, Axel Rominger, Veronika Reinisch, Johannes Levin
Publikováno v:
Current Alzheimer Research. 13:475-486
Late life depression (LLD) even in subsyndromal stages shows high conversion rates from cognitively normal (CN) to mild cognitive impairment (MCI). Results of [(18)F]-fluorodesoxyglucose positron-emission-tomography (FDG-PET) were inconsistent in LLD
Autor:
Igor, Krashenyi, Javier, Ramírez, Anton, Popov, Juan Manuel, Górriz, The Alzheimer's Disease Neuroimaging Initiative
Publikováno v:
Current Alzheimer Research. 13:545-556
Alzheimer's disease (AD) is a chronic neurodegenerative disease of the central nervous system that has no cure and leads to death. One of the most prevalent tools for AD diagnosis is magnetic resonance imaging (MRI), because of its capability to visu
Autor:
Matthias Brendel, Axel Rominger, Sonja Därr, Marcus Högenauer, Andreas Delker, M. Weiss, Alzheimer’s Disease Neuroimaging Initiative, Peter Bartenstein
Publikováno v:
Current Alzheimer Research. 13:597-607
Introduction: Magnet resonance image (MRI)-based segmentations are widely used for clinical brain research, especially in conjunction with positron-emission-tomography (PET). Although artifacts due to segmentation errors arise commonly, the impact of
Autor:
Antonio Martinez-Torteya, Hugo Gomez-Rueda, Victor Trevino, Joshua Farber, Jose Tamez-Pena, null For the Alzheimer’s Disease Neuroimaging Initiative
Publikováno v:
Current Alzheimer research. 15(8)
Background: Diagnosing Alzheimer’s disease (AD) in its earliest stages is important for therapeutic and support planning. Similarly, being able to predict who will convert from mild cognitive impairment (MCI) to AD would have clinical implications.
Autor:
Jongmin Lee, Chan Mi Kim, Jihye Hwang, Jae-Young Koh, Jee Hoon Roh, Jae-Hong Lee, Alzheimer’s Disease Neuroimaging Initiative
Publikováno v:
Current Alzheimer Research. 12:563-571
Alzheimer's disease (AD) is the most common neurodegenerative disorder pathologically characterized by amyloid-beta (Aβ) plaques and neurofibrillary tangles. The aggregation of Aβ precedes tau pathologies in AD; however, the causal relation between
Autor:
Nishant Verma, S. Natasha Beretvas, Belen Pascual, Joseph C. Masdeu, Mia K. Markey, null The Alzheimer's Disease Neuroimaging Initiative
Publikováno v:
Current Alzheimer research. 15(5)
Background: Combining optimized cognitive (Alzheimer's Disease Assessment Scale- Cognitive subscale, ADAS-Cog) and atrophy markers of Alzheimer's disease for tracking progression in clinical trials may provide greater sensitivity than currently used
Autor:
Zhigang Qi, Hong Liang, Peipeng Liang, Alzheimer’s Disease Neuroimaging Initiative, Kuncheng Li, Jie Xiang
Publikováno v:
Current Alzheimer Research. 11:389-398
Purpose: Previous studies have shown that the strength of the low frequency fluctuation in the medial-line brain areas are abnormally reduced in mild cognitive impairment (MCI) and Alzheimer’s disease (AD) patients. The purpose of this study was to